Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Market Data
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
J&J's abiraterone improves survival in first Phase III prostate cancer trial
10 September 2010
Johnson & Johnson's billion dollar acquisition of Cougar Biotechnology last year to gain access to a novel, hormonal anticancer, looks like it may be paying ...
Europe's top universities threaten €2 billion pharma innovation project boycott
10 September 2010
Twenty-two leading research-intensive universities in Europe have strongly criticised the €2 billion Innovative Medicines Initiative (IMI), a public-private ...
Victoza gets NICE green light
10 September 2010
NICE, the health technology appraisal institute in England and Wales, is recommending that Novo Nordisk's GLP-1 agonist Victoza (liraglutide) for type 2 ...
First approval for Daiichi Sankyo's long-acting flu drug, in Japan
10 September 2010
Daiichi Sankyo has received the first approval worldwide, in Japan, for the long-acting neuraminidase inhibitor, laninamivir, which it will market as ...
 
Ark 'extends runway until 2013' amid further restructuring
10 September 2010
Ark Therapeutics, the UK firm that suffered a catastrophic setback in December last year when the CHMP rejected its gene therapy candidate Cerepro (sitimagene ceradenovec) for the treatment of brain ...
Pevion appoints new CEO amid CHF10 million fundraising
10 September 2010
Pevion, the privately-held Swiss vaccine company, has appointed Dr Evert Kueppers CEO and has raised CHF10 million ($9.9 million) in a private financing round. Dr Kueppers succeeds Thomas Stauffer ...
Shire joins orphan disease rush with $500 million Acceleron deal
09 September 2010
Shire has joined the ranks of large pharmaceutical companies pursuing deals and acquisitions in the orphan disease market by acquiring the rights to Acceleron's Duchenne's muscular dystrophy (DMD) ...
GSK appoints banking M&A specialist as new CFO
09 September 2010
GlaxoSmithKline has appointed a former Goldman Sachs managing director and partner to replace its chief financial officer Julian Heslop . Simon Dingemans has been appointed CFO designate and ...
 
FDA panel to review Boehringer's Pradaxa on 20 September
10 September 2010
The US FDA's cardiovascular and renal drugs advisory committee will review Boehringer Ingelheim's direct thrombin inhibitor Pradaxa (dabigatran) for the prevention of stroke in patients with atrial ...
Green Cross's novel Parkinson's agent moves forward
10 September 2010
Green Cross of South Korea expects to complete the first clinical trial with its novel potential therapy for Parkinson's disease in the middle of October. Dosing in 40 healthy male volunteers began ...
Once-monthly minodronic acid filed for approval in Japan
10 September 2010
Astellas and local partner Ono have filed for the Japanese approval of a once-monthly formulation of the oral bisphosphonate, minodronic acid hydrate, for the treatment of osteoporosis. The product ...
US FDA delays decision date for Questcor's Acthar for infantile spasms
09 September 2010
The US FDA has postponed the PDUFA date for a supplemental approval of Questcor's HP Acthar gel (repository corticotropin injection) for infantile spasms, due largely to labelling issues. The delay ...
 
Allergan to pay $600 million settle US Botox probe;drops off-label suit
10 September 2010
Officials at the US Department of Justice report that drug maker Allergan has agreed to plead guilty to a single misdemeanour charge and pay $600 million to resolve a years-long federal probe ...
NICE wants more Abilify data
10 September 2010
NICE, the HTA institute for England and Wales, says that it needs more information from Bristol-Myers Squibb and Otsuka Pharmaceuticals before it can assess whether or not to recommend NHS uptake of ...
Hong Kong favours Synflorix for immunisation programme
10 September 2010
The health authorities in Hong Kong are to switch the provider of pneumococcal conjugate vaccine (PCV) to the government's childhood immunisation programme from next month. Following a competitive ...
New EU law calls for fewer use of animals in scientific research
09 September 2010
The European Parliament has approved new legislation on animal testing that requires, among other things, EU member states to assess the animal welfare implications of each scientific experiment ...
 
PEOPLE
AstraZeneca makes appointment in Russia AstraZeneca has appointed Nenad Pavletic general manager of its Russian division. He succeeds ...
Oncothyreon appoints new CFO The US biotechnology company Oncothyreon has appointed Julie Eastland chief financial officer and ...
Inspire appoints new senior VP Inspire Pharmaceuticals, a US-based biopharmaceutical company focused on the R&D of prescription ...
>> More People News...

EXPERT VIEW
Avandia and the need for more transparency
10 September 2010
Ian Schofield
Later this month we will learn whether the US and EU regulators want GlaxoSmithKline's diabetes ...

What Viehbacher sees in Genzyme
09 September 2010

Sanofi-Aventis's proposed acquisition of Genzyme, announced on 29 August, is a major acceleration ...

 2010 Scrip 100 - Mixed fortunes on the R&D fr...

2010 Scrip 100 - Mixed fortunes on the R&D front
23 August 2010

Continued problems with anti-obesity drugs, more measures designed to improve R&D efficiency, and ...

2010 Scrip 100 - Pharma muscles into emerging markets with M&A
23 August 2010

This year has seen many firms facing patent expiries on core revenue generators. The current ...

MULTIMEDIA
Scrip 100: Trends driving pharma in 2010-2011 01 September 2010

Get the Flash Player to see this player.

AstraZeneca makes a narrow escape from UK Seroquel probe
20 August 2010
Elizabeth Sukkar
AstraZeneca's blockbuster atypical antipsychotic Seroquel (quetiapine) has been in the news quite a ...

Calling German and Spanish Physicists: the EMA Needs You
13 July 2010
Maureen Kenny
German or Spanish physicists hoping for a career change involving a move to London at the end of ...

GW high on pipeline of cannabis extracts
23 August 2010
Katie McQue
GW Pharma has enjoyed recent success with its cannabinoid extract product Sativex (nabiximols), ...

Scrip's CPhI, ICSE, P-MEC and BioPh Show Preview
18 August 2010
CPhl Worldwide - with ICSE, P-MEC and BioPh - makes its return to Paris at the popular Paris - Nord ...

EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm